Pax3 mRNA is decreased in the hearts of rats with experimental diaphragmatic hernia

S Gonzalez-Reyes1, V Fernandez-Dumont, W Martinez-Calonge

  • 1Departamento de Cirugia Pediatrica, Hospital Universitario "La Paz", P. de la Castellana 261, 28046 Madrid, Spain. jatovar.hulp@salud.madrid.org

Insights

Nitrofen exposure in rats causes congenital diaphragmatic hernia (CDH) with heart hypoplasia. This study found decreased Pax3 gene expression in affected embryonic rat hearts, suggesting a potential target for interventions.

Area of Science:

  • Developmental Biology
  • Genetics
  • Toxicology

Background:

  • Congenital diaphragmatic hernia (CDH) in rats induced by nitrofen is associated with heart hypoplasia and cardiovascular defects.
  • Neural crest cell signaling is implicated in nitrofen's mechanism of action.
  • Pax3 gene expression is crucial for cardiac neural crest cell migration to the developing heart.

Purpose of the Study:

  • To investigate changes in Pax3 gene expression in rat embryos and fetuses exposed to nitrofen.
  • To determine if Pax3 expression is altered at two specific gestational time points (E15 and E21) following nitrofen exposure.

Main Methods:

  • Pregnant rats were administered nitrofen or vehicle on day E9.5 of gestation.
  • Fetuses were collected on E15 and E21 for analysis.
  • Heart-to-body weight ratio was measured to assess heart hypoplasia.
  • Real-time polymerase chain reaction (PCR) was used to quantify Pax3 mRNA expression in heart tissues.

Main Results:

  • Nitrofen-exposed fetuses exhibited significantly reduced heart-to-body weight ratios, indicating heart hypoplasia.
  • Pax3 mRNA expression was significantly decreased in the hearts of nitrofen-exposed embryos on E15.
  • While Pax3 expression remained lower in nitrofen-exposed fetuses on E21, the difference was not statistically significant.

Conclusions:

  • Pax3 is underexpressed in the hearts of nitrofen-exposed rat embryos prior to term.
  • The findings suggest that altered Pax3 expression is a consequence of nitrofen exposure during development.
  • Pax3 may represent a therapeutic target for future prenatal interventions aimed at mitigating nitrofen-induced developmental defects.

Related Concept Videos